Crossref
Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects
Oncology Research · 2026 · 1-10
DOI: 10.32604/or.2026.089420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Yu Chang und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chang, Y., Qiao, N., Wang, Q., Bao, C., Su, Y., Lei, X., Yang, M., & Hu, Y. (2026). Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.089420
Vancouver
Chang Y, Qiao N, Wang Q, Bao C, Su Y, Lei X, et al. Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.089420
BibTeX
@article{Chang2026,
author = {Chang, Yu and Qiao, Na and Wang, Qingqing and Bao, Chan and Su, Yani and Lei, Xia and Yang, Mingyi and Hu, Yunfeng},
title = {Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects},
journal = {Oncology Research},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/or.2026.089420}
}
EUVIMED